A Phase II, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of a Humanized Anti-Interferon--y Monoclonal Antibody (HuZAF) Administerd to Patients with Moderate to Severe Crohn's Disease

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/029/30/04